Brainflamme: The central role of CD6 receptor in the regulation of T-lymphocyte activation and as a therapeutic target in neuroinflammation (Q2907040): Difference between revisions
Jump to navigation
Jump to search
(Removed claim: co-financing rate (P837): 85.0 percentage) |
(Changed an Item: Import item from Portugal) |
||||||||||
| Property / budget | Property / budget | ||||||||||
| 235,804.05 Euro
| ||||||||||
| Property / EU contribution | Property / EU contribution | ||||||||||
| 200,433.44 Euro
| ||||||||||
| Property / priority axis | |||||||||||
| Property / priority axis: Strengthening research, technological development and innovation (OT1) / rank | |||||||||||
Normal rank | |||||||||||
| Property / co-financing rate | |||||||||||
85.0 percent
| |||||||||||
| Property / co-financing rate: 85.0 percent / rank | |||||||||||
Normal rank | |||||||||||
Revision as of 02:10, 5 November 2022
Project Q2907040 in Portugal
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Brainflamme: The central role of CD6 receptor in the regulation of T-lymphocyte activation and as a therapeutic target in neuroinflammation |
Project Q2907040 in Portugal |
Statements
200,433.44 Euro
0 references
235,804.05 Euro
0 references
85.0 percent
0 references
1 July 2018
0 references
30 June 2021
0 references
INSTITUTO DE BIOLOGIA MOLECULAR E CELULAR - IBMC
0 references
Q2985732 (Deleted Item)
0 references
41°8'58.02"N, 8°36'38.84"W
0 references
Porto
0 references
Identifiers
POCI-01-0145-FEDER-032296
0 references